α-synuclein astrogliopathy: A possible specific feature in α-synucleinopathy

Shunsuke Koga; Koji Kasanuki; Dennis W. Dickson

doi:10.1111/neup.12371

α-synuclein astrogliopathy: A possible specific feature in α-synucleinopathy

Shunsuke Koga, Koji Kasanuki, Dennis W. Dickson

Neuroscience

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	379-381
Number of pages	3
Journal	Neuropathology
Volume	37
Issue number	4
DOIs	https://doi.org/10.1111/neup.12371
State	Published - Aug 2017

ASJC Scopus subject areas

Pathology and Forensic Medicine
Clinical Neurology

Access to Document

10.1111/neup.12371

Cite this

@article{1bf76154ed4540519f3b5023d97c38a1,

title = "α-synuclein astrogliopathy: A possible specific feature in α-synucleinopathy",

author = "Shunsuke Koga and Koji Kasanuki and Dickson, {Dennis W.}",

note = "Funding Information: We would like to thank the patients and their families who donated brains to help further the scientific understanding of neurodegeneration. The authors would also like to acknowledge Dr. Peter Davies (Feinstein Institute for Medical Research, LIJ-North Shore Health System, NY) for the monoclonal anti-tau antibody CP13, Linda Rousseau (Mayo Clinic, Jacksonville, FL) and Virginia Phillips (Mayo Clinic) for histologic support, and Monica Castanedes-Casey (Mayo Clinic) for immunohistochemistry support. Supported by NIH grant P50 NS072187 and a Jaye F. and Betty F. Dyer Foundation Fellowship.",

year = "2017",

month = aug,

doi = "10.1111/neup.12371",

language = "English (US)",

volume = "37",

pages = "379--381",

journal = "Neuropathology",

issn = "0919-6544",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - α-synuclein astrogliopathy

T2 - A possible specific feature in α-synucleinopathy

AU - Koga, Shunsuke

AU - Kasanuki, Koji

AU - Dickson, Dennis W.

N1 - Funding Information: We would like to thank the patients and their families who donated brains to help further the scientific understanding of neurodegeneration. The authors would also like to acknowledge Dr. Peter Davies (Feinstein Institute for Medical Research, LIJ-North Shore Health System, NY) for the monoclonal anti-tau antibody CP13, Linda Rousseau (Mayo Clinic, Jacksonville, FL) and Virginia Phillips (Mayo Clinic) for histologic support, and Monica Castanedes-Casey (Mayo Clinic) for immunohistochemistry support. Supported by NIH grant P50 NS072187 and a Jaye F. and Betty F. Dyer Foundation Fellowship.

PY - 2017/8

Y1 - 2017/8

UR - http://www.scopus.com/inward/record.url?scp=85013931541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013931541&partnerID=8YFLogxK

U2 - 10.1111/neup.12371

DO - 10.1111/neup.12371

M3 - Letter

C2 - 28244166

AN - SCOPUS:85013931541

SN - 0919-6544

VL - 37

SP - 379

EP - 381

JO - Neuropathology

JF - Neuropathology

IS - 4

ER -

α-synuclein astrogliopathy: A possible specific feature in α-synucleinopathy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this